Goldman Sachs plans to trim its staffing by 3% to 5% in an annual performance review process this spring, said a source ...
The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...
The most recent trading session ended with Goldman Sachs (GS) standing at $559.67, reflecting a -1.41% shift from the previouse trading day's closing. The stock fell short of the S&P 500, which ...
Technology is the second worst-performing S&P 500 sector year-to-date with about an 8 per cent loss, after consumer ...
4don MSN
The U.S. stock market’s sell-off cut deeper on Monday as Wall Street questioned how much pain President Donald Trump will let ...
Novo Nordisk is lowering the price of its weight-loss drug Wegovy to $499 per month for some patients paying out of pocket.
Goldman Sachs Asset Management announced the creation ... halting and reversing biodiversity loss. The fund will make disclosures in line with the European Union’s Sustainable Finance Disclosure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback